Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 8 May 2023
First Online: 29 June 2023
Declarations
:
: Margarite Matossian declares that she has no conflict of interest. Nan Chen has received personal fees from AstraZeneca and Gilead Sciences. Rita Nanda serves on the advisory boards for AstraZeneca, BeyondSpring, Fujifilm, GE, Gilead, Infinity, iTeos, Merck, OBI, Oncosec, Sanofi, Seagen. Rita Nanda has received research funding from Arvinas, AstraZeneca, Celgene, Corcept Therapeutics, Genentech/Roche, Gilead/Immunomedics, Merck, OBI Pharma, OncoSec, Pfizer, Relay, Seattle Genetics, Sun Pharma, Taiho.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
